MTOR and cervical carcinoma: In cervical cancer, underlying infections with high-risk human papillomavirus (HPV) provide a particularly strong rationale for mTOR inhibition, as the mTOR pathway appears to play a key role in virus/host cell crosstalk via oncoproteins E6 and E7.